Chinese Expert Consensus on Medication Safety in Polypharmacy in Type 2 Diabetics with Chronic Kidney Disease

Chinese Expert Consensus on Medication Safety in Polypharmacy in Type 2 Diabetics with Chronic Kidney Disease

Diabetes is a serious public health problem worldwide. The prevalence of chronic kidney disease (CKD) secondary to type 2 diabetes mellitus (T2DM) is growing with the increase of T2DM prevalence. There is no comprehensive guideline on medication safety in polypharmacy in patients with T2DM-related C...

Full description

Bibliographic Details
Main Author: Chinese Medical Association Clinical Pharmacy Branch
Format: Article
Language:zho
Published: Chinese General Practice Publishing House Co., Ltd 2022-08-01
Series:Zhongguo quanke yixue
Subjects:
diabetes mellitus, type 2|chronic kidney disease (ckd)|renal insufficiency, chronic|polypharmacy|expert consensus|guideline
Online Access:https://www.chinagp.net/fileup/1007-9572/PDF/yx202201304.pdf

Internet

https://www.chinagp.net/fileup/1007-9572/PDF/yx202201304.pdf

Similar Items